vs

Side-by-side financial comparison of KILROY REALTY CORP (KRC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

KILROY REALTY CORP is the larger business by last-quarter revenue ($272.2M vs $225.6M, roughly 1.2× Organogenesis Holdings Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 6.3%, a 13.1% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs -5.0%). KILROY REALTY CORP produced more free cash flow last quarter ($450.3M vs $34.8M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -1.2%).

Kilroy Realty Corp is a leading U.S. real estate investment trust that develops, owns, and operates premium office, life science, and mixed-use properties primarily across high-growth West Coast markets including Los Angeles, San Francisco, Seattle, and San Diego. It serves tenants across the technology, life sciences, media, and creative sectors, with a core focus on delivering sustainable, future-ready workspaces tailored to modern business needs.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

KRC vs ORGO — Head-to-Head

Bigger by revenue
KRC
KRC
1.2× larger
KRC
$272.2M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+83.1% gap
ORGO
78.1%
-5.0%
KRC
Higher net margin
ORGO
ORGO
13.1% more per $
ORGO
19.4%
6.3%
KRC
More free cash flow
KRC
KRC
$415.5M more FCF
KRC
$450.3M
$34.8M
ORGO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-1.2%
KRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KRC
KRC
ORGO
ORGO
Revenue
$272.2M
$225.6M
Net Profit
$17.1M
$43.7M
Gross Margin
Operating Margin
28.1%
Net Margin
6.3%
19.4%
Revenue YoY
-5.0%
78.1%
Net Profit YoY
-73.7%
469.5%
EPS (diluted)
$0.11
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRC
KRC
ORGO
ORGO
Q4 25
$272.2M
$225.6M
Q3 25
$279.7M
$150.9M
Q2 25
$289.9M
$101.0M
Q1 25
$270.8M
$86.7M
Q4 24
$286.4M
$126.7M
Q3 24
$289.9M
$115.2M
Q2 24
$280.7M
$130.2M
Q1 24
$278.6M
$110.0M
Net Profit
KRC
KRC
ORGO
ORGO
Q4 25
$17.1M
$43.7M
Q3 25
$162.3M
$21.6M
Q2 25
$79.6M
$-9.4M
Q1 25
$43.7M
$-18.8M
Q4 24
$65.0M
$7.7M
Q3 24
$57.7M
$12.3M
Q2 24
$54.5M
$-17.0M
Q1 24
$55.7M
$-2.1M
Gross Margin
KRC
KRC
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
KRC
KRC
ORGO
ORGO
Q4 25
28.1%
Q3 25
13.7%
Q2 25
-12.5%
Q1 25
-30.9%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
-10.7%
Q1 24
-3.5%
Net Margin
KRC
KRC
ORGO
ORGO
Q4 25
6.3%
19.4%
Q3 25
58.0%
14.3%
Q2 25
27.4%
-9.3%
Q1 25
16.1%
-21.7%
Q4 24
22.7%
6.1%
Q3 24
19.9%
10.7%
Q2 24
19.4%
-13.1%
Q1 24
20.0%
-1.9%
EPS (diluted)
KRC
KRC
ORGO
ORGO
Q4 25
$0.11
$0.31
Q3 25
$1.31
$0.11
Q2 25
$0.57
$-0.10
Q1 25
$0.33
$-0.17
Q4 24
$0.50
$0.05
Q3 24
$0.44
$0.09
Q2 24
$0.41
$-0.13
Q1 24
$0.42
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRC
KRC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$179.3M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.4B
$300.1M
Total Assets
$10.9B
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRC
KRC
ORGO
ORGO
Q4 25
$179.3M
$93.7M
Q3 25
$372.4M
$63.7M
Q2 25
$193.1M
$73.1M
Q1 25
$146.7M
$110.0M
Q4 24
$165.7M
$135.6M
Q3 24
$625.4M
$94.3M
Q2 24
$835.9M
$89.9M
Q1 24
$855.0M
$88.6M
Total Debt
KRC
KRC
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
KRC
KRC
ORGO
ORGO
Q4 25
$5.4B
$300.1M
Q3 25
$5.5B
$255.1M
Q2 25
$5.4B
$233.2M
Q1 25
$5.4B
$242.9M
Q4 24
$5.4B
$262.9M
Q3 24
$5.4B
$278.5M
Q2 24
$5.4B
$263.5M
Q1 24
$5.4B
$278.0M
Total Assets
KRC
KRC
ORGO
ORGO
Q4 25
$10.9B
$598.7M
Q3 25
$11.0B
$509.8M
Q2 25
$10.9B
$461.1M
Q1 25
$10.9B
$467.4M
Q4 24
$10.9B
$497.9M
Q3 24
$11.4B
$446.3M
Q2 24
$11.5B
$443.2M
Q1 24
$11.6B
$458.5M
Debt / Equity
KRC
KRC
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRC
KRC
ORGO
ORGO
Operating Cash FlowLast quarter
$566.3M
$39.4M
Free Cash FlowOCF − Capex
$450.3M
$34.8M
FCF MarginFCF / Revenue
165.4%
15.4%
Capex IntensityCapex / Revenue
42.6%
2.1%
Cash ConversionOCF / Net Profit
33.10×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$833.0M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRC
KRC
ORGO
ORGO
Q4 25
$566.3M
$39.4M
Q3 25
$176.6M
$3.1M
Q2 25
$143.7M
$-32.9M
Q1 25
$136.9M
$-19.9M
Q4 24
$541.1M
$10.9M
Q3 24
$176.3M
$8.7M
Q2 24
$88.7M
$4.7M
Q1 24
$167.9M
$-10.2M
Free Cash Flow
KRC
KRC
ORGO
ORGO
Q4 25
$450.3M
$34.8M
Q3 25
$148.7M
$844.0K
Q2 25
$118.4M
$-36.5M
Q1 25
$115.6M
$-23.6M
Q4 24
$440.8M
$7.6M
Q3 24
$147.2M
$6.1M
Q2 24
$69.5M
$2.9M
Q1 24
$151.9M
$-12.4M
FCF Margin
KRC
KRC
ORGO
ORGO
Q4 25
165.4%
15.4%
Q3 25
53.1%
0.6%
Q2 25
40.9%
-36.1%
Q1 25
42.7%
-27.2%
Q4 24
153.9%
6.0%
Q3 24
50.8%
5.3%
Q2 24
24.7%
2.2%
Q1 24
54.5%
-11.3%
Capex Intensity
KRC
KRC
ORGO
ORGO
Q4 25
42.6%
2.1%
Q3 25
10.0%
1.5%
Q2 25
8.7%
3.6%
Q1 25
7.9%
4.2%
Q4 24
35.0%
2.7%
Q3 24
10.1%
2.2%
Q2 24
6.8%
1.4%
Q1 24
5.7%
2.0%
Cash Conversion
KRC
KRC
ORGO
ORGO
Q4 25
33.10×
0.90×
Q3 25
1.09×
0.14×
Q2 25
1.81×
Q1 25
3.13×
Q4 24
8.32×
1.43×
Q3 24
3.06×
0.71×
Q2 24
1.63×
Q1 24
3.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons